MARINI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 170
EU - Europa 100
AS - Asia 85
SA - Sud America 17
Totale 372
Nazione #
US - Stati Uniti d'America 167
SG - Singapore 35
CN - Cina 25
IE - Irlanda 20
BR - Brasile 14
DE - Germania 14
SE - Svezia 13
GB - Regno Unito 11
UA - Ucraina 10
FR - Francia 9
HK - Hong Kong 8
IN - India 7
IT - Italia 7
RU - Federazione Russa 6
AR - Argentina 3
FI - Finlandia 3
TR - Turchia 3
VN - Vietnam 3
CA - Canada 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CH - Svizzera 1
ES - Italia 1
IQ - Iraq 1
KZ - Kazakistan 1
MX - Messico 1
NL - Olanda 1
NO - Norvegia 1
Totale 372
Città #
Chandler 38
Singapore 29
Dublin 19
Ashburn 14
Jacksonville 12
Beijing 11
Munich 9
Princeton 9
Hong Kong 8
Altamura 5
Nanjing 5
New York 5
Dallas 4
Los Angeles 4
Southend 4
The Dalles 4
Atlanta 3
Dearborn 3
Denver 3
Wilmington 3
Bengaluru 2
Buffalo 2
Dong Ket 2
Hanover 2
Manchester 2
Santa Clara 2
Santo André 2
Tampa 2
Tianjin 2
Washington 2
Acaraú 1
Agrolândia 1
Almaty 1
Amsterdam 1
Ankara 1
Ann Arbor 1
Arrecifes 1
Baghdad 1
Belgorod 1
Belo Horizonte 1
Belém 1
Bexley 1
Boardman 1
Cambridge 1
Chicago 1
Chieti 1
Curitiba 1
Duartina 1
Edinburgh 1
Fuzhou 1
Hebei 1
Helsinki 1
Houston 1
Imperatriz 1
Ituzaingó 1
Izmir 1
La Rioja 1
London 1
Miami 1
Monmouth Junction 1
Montreal 1
Mumbai 1
Norwalk 1
Nossa Senhora das Dores 1
Nova Friburgo 1
Oslo 1
Philadelphia 1
Phoenix 1
Poplar 1
Querétaro 1
Redondo Beach 1
Rio de Janeiro 1
Rome 1
Roubaix 1
San Mateo 1
Shenyang 1
Sinop 1
São José dos Campos 1
Tirana 1
Tongling 1
Turku 1
Vancouver 1
Vinh 1
Woodbridge 1
Zhengzhou 1
Totale 267
Nome #
Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1G93A mouse, a model of amyotrophic lateral sclerosis 116
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 97
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 95
Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study 93
Totale 401
Categoria #
all - tutte 1.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 0 0 4 0 0 2 5 6 2
2021/202217 0 1 0 1 2 0 0 1 0 0 5 7
2022/202382 5 17 6 12 5 16 3 8 6 0 4 0
2023/202442 2 1 3 1 4 17 8 0 0 2 0 4
2024/202587 4 16 4 1 2 6 9 0 8 7 11 19
2025/202674 11 4 11 29 17 2 0 0 0 0 0 0
Totale 401